← Evidence map

ArticleCNS drugs2019

Authors' Reply to Tsivgoulis et al.: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A likelihood to Achieve No Evidence of Disease Activity or Harm Analysis".

Dimitrios Papadopoulos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Authors' Reply to Tsivgoulis et al.: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A likelihood to Achieve No Evidence of Disease Activity or Harm Analysis". | OpenQuestion